Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Alment Praktiserende Læge Michael Kirkeby Hoffmann ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5%   Bankruptcy risk   1.5% 1.3% 1.2% 1.1% 1.4% 2.3% 4.7% 4.7%   Credit score (0-100)   79 81 81 82 78 64 45 45   Credit rating   A A A A A BBB BBB BBB   Credit limit (kDKK)   76.5 259.5 522.1 978.3 265.2 0.6 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,815 2,956 3,671 3,608 3,499 3,786 0.0 0.0   EBITDA   976 1,078 1,276 915 693 831 0.0 0.0   EBIT   800 823 956 679 424 553 0.0 0.0   Pre-tax profit (PTP)   2,712.7 2,020.9 1,678.7 5,951.9 1,662.4 -458.6 0.0 0.0   Net earnings   2,649.2 1,671.1 1,479.0 5,507.6 1,896.5 -606.7 0.0 0.0   Pre-tax profit without non-rec. items   2,713 2,021 1,679 5,952 1,662 -459 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   918 705 4,384 4,719 4,725 4,614 0.0 0.0   Shareholders equity total   14,916 16,479 24,405 29,799 31,581 30,857 30,609 30,609   Interest-bearing liabilities   20.9 0.0 1,827 1,743 1,707 1,696 0.0 0.0   Balance sheet total (assets)   19,359 21,191 31,681 37,052 38,657 38,420 30,609 30,609   Net Debt   -2,300 -2,889 -10,570 -11,723 -10,762 -11,922 -29,999 -29,999     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,815 2,956 3,671 3,608 3,499 3,786 0.0 0.0   Gross profit growth   11.6% 5.0% 24.2% -1.7% -3.0% 8.2% -100.0% 0.0%   Employees   3 3 3 3 3 3 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   19,359 21,191 31,681 37,052 38,657 38,420 30,609 30,609   Balance sheet change%   19.5% 9.5% 49.5% 17.0% 4.3% -0.6% -20.3% 0.0%   Added value   975.5 1,078.3 1,276.3 915.1 660.3 831.1 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   110 -503 3,560 52 -310 -437 -4,614 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   28.4% 27.9% 26.0% 18.8% 12.1% 14.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   18.1% 11.9% 7.4% 18.6% 9.5% 3.6% 0.0% 0.0%   ROI %   23.4% 15.2% 9.1% 21.8% 11.0% 4.2% 0.0% 0.0%   ROE %   19.4% 10.6% 7.2% 20.3% 6.2% -1.9% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   77.0% 77.7% 77.0% 80.4% 81.7% 80.3% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -235.8% -267.9% -828.2% -1,281.0% -1,553.2% -1,434.4% 0.0% 0.0%   Gearing %   0.1% 0.0% 7.5% 5.8% 5.4% 5.5% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   1,706.4% 3,747.9% 31.4% 23.9% 111.3% 108.4% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.7 0.9 2.4 2.7 2.4 2.4 0.0 0.0   Current Ratio   0.7 0.9 2.4 2.7 2.4 2.4 0.0 0.0   Cash and cash equivalent   2,321.3 2,889.1 12,397.3 13,466.1 12,469.1 13,617.6 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -2,945.5 -2,818.0 -3,657.5 -4,411.4 -4,077.6 -4,063.9 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   325 359 425 305 220 277 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   325 359 425 305 231 277 0 0   EBIT / employee   267 274 319 226 141 184 0 0   Net earnings / employee   883 557 493 1,836 632 -202 0 0